ETF Series Solutions. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Definium Therapeutics IncDFTX | 4.77% | $64.44K | 1,370 |
| Pearson PLC | 2.56% | $45.97K | 2,182 |
| GSK PLC | 2.46% | $44.11K | 1,264 |
| Novartis AG | 2.53% | $42.41K | 218 |
| Roche Holding AG | 2.50% | $41.94K | 82 |
| LifeStance Health Group IncLFST | 3.04% | $41.10K | 3,838 |
| Ipsen SA | 2.60% | $40.16K | 182 |
| Acadia Healthcare Co IncACHC | 2.90% | $39.22K | 1,328 |
| ACADIA Pharmaceuticals IncACAD | 2.89% | $39.06K | 1,544 |
| MapLight Therapeutics IncMPLT | 2.89% | $38.99K | 1,088 |
| AbbVie IncABBV | 2.72% | $36.74K | 146 |
| BrightSpring Health Services IBTSG | 2.70% | $36.54K | 524 |
| Revvity IncRVTY | 2.68% | $36.27K | 326 |
| Bright Horizons Family SolutioBFAM | 2.65% | $35.87K | 506 |
| Johnson & JohnsonJNJ | 2.59% | $35.05K | 138 |
| Brainsway LtdBWAY | 2.58% | $34.90K | 2,250 |
| Anavex Life Sciences CorpAVXL | 2.53% | $34.23K | 13,216 |
| BioMarin Pharmaceutical IncBMRN | 2.52% | $33.99K | 594 |
| Repligen CorpRGEN | 2.50% | $33.84K | 248 |
| Supernus Pharmaceuticals IncSUPN | 2.50% | $33.77K | 726 |
| Jazz Pharmaceuticals PLC | 2.50% | $33.74K | 140 |
| Eli Lilly & CoLLY | 2.49% | $33.58K | 28 |
| Bristol-Myers Squibb CoBMY | 2.47% | $33.42K | 580 |
| Vanda Pharmaceuticals IncVNDA | 2.45% | $33.15K | 5,416 |
| Graham Holdings CoGHC | 2.37% | $31.96K | 28 |
| Grand Canyon Education IncLOPE | 2.31% | $31.20K | 218 |
| Pfizer IncPFE | 2.25% | $30.39K | 1,262 |
| Neuren Pharmaceuticals Ltd | 3.23% | $30.28K | 3,554 |
| Stride IncLRN | 2.12% | $28.63K | 332 |
| Teva Pharmaceutical Industries | 2.35% | $10.66K | 962 |
| KPJ Healthcare Bhd | 2.51% | $8.33K | 42,600 |
| H Lundbeck A/S | 2.29% | $4.74K | 4,768 |
| Medicover AB | 2.63% | $3.67K | 1,496 |
| First American Government ObliCash or money market | 0.21% | $2.89K | 2,894 |
| Life Healthcare Group Holdings | 2.52% | $2.08K | 53,486 |
| Otsuka Holdings Co Ltd | 2.95% | $245 | 600 |
| Sumitomo Pharma Co Ltd | 2.60% | $216 | 3,800 |
| Takeda Pharmaceutical Co Ltd | 2.35% | $195 | 1,000 |
| Shionogi & Co Ltd | 2.29% | $190 | 1,800 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.